Home / Pharmaceutical / The Pharmaceutical Market: Bangladesh

The Pharmaceutical Market: Bangladesh

Published: Dec 2014 | No Of Pages: 113 | Published By: Espicom

Product Synopsis

THE PHARMACEUTICAL MARKET: BANGLADESH - REVIEW
 
While geographic diversification and investment into the pharmaceutical and healthcare sector of emerging economies, such as Bangladesh, may be a favourable strategy for any multinational pharmaceutical company - it is vital that a company recognises both the rewards and the risks present in a market. With regards to assessing risks in the Bangladeshi healthcare sector, we have identified those emanating from the state's political/economic profile (such as high inflation) and industry specific dangers (such as low per-capita spending and poor access to healthcare facilities) that call into question the likelihood of anticipated returns being realised over the assessed time period.
 
Headline Expenditure Projections
 
  • Pharmaceuticals: BDT111.10bn (US$1.50bn) in 2011 to BDT124.25bn (US$1.54bn) in 2012; +11.8% in local currency terms and +2.5% in US dollar terms.
  • Healthcare: BDT271.27bn (US$3.66bn) in 2011 to BDT304.45bn (US$3.76bn) in 2012; +12.2% in local currency terms and +12.8% in US dollar terms.
  • Medical devices: BDT12.91bn (US$174mn) in 2011 to BTD14.47bn (US$179mn) in 2012; +12.1% in local currency terms and +2.7% in US dollar terms.
  • Risk/Reward Ratings : While geographic diversification and investment into the pharmaceutical and healthcare sector of emerging economies such as Bangladesh may be a favourable strategy for any multinational pharmaceutical company - it is vital that a company recognises both the rewards and the risks present in a market. For Q113, Bangladesh has retained its 17th position out of the 18 regional markets surveyed. Its overall rating of 38.3, remains considerably lower than the average for the region.
Competitive Landscape
 
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
BMI Industry View7
SWOT9
Political11
Economic12
Business Environment13
Industry Forecast14
Pharmaceutical Market Forecast14
 
Table: Pharmaceutical Sales, Historical Data And Forecasts15
 
Healthcare Market Forecast16
 
Table: Healthcare Expenditure Trends, Historical Data And Forecasts17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts18
 
Prescription Drug Market Forecast19
 
Table: Prescription Drug Market Indicators, Historical Data And Forecasts20
 
Patented Drug Market Forecast21
 
Table: Patented Drug Market Indicators, Historical Data And Forecasts22
 
OTC Medicine Market Forecast23
 
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts24
 
Generic Medicines Market Forecast25
 
Table: Generics Drug Market Indicators, Historical Data And Forecasts26
 
Pharmaceutical Trade Forecast27
 
Table: Pharmaceutical Trade Data And Forecasts29
Table: Pharmaceutical Trade Data And Forecasts BDT30
 
Other Healthcare Data31
Key Risks To BMI's Forecast Scenario33
Macroeconomic Forecasts34
Economic Analysis34
Lower Investment, Slower Growth34
Export Sector To Suffer35
Service Sector Hit Hard36
Bright Spots Amid Political Crisis36
 
Table: Bangladesh - Economic Activity37
 
Industry Risk Reward Ratings38
Asia Risk/Reward Ratings38
Bangladesh Risk/Reward Ratings44
Rewards44
Risks44
Market Overview46
Industry Trends And Developments47
Epidemiology47
Healthcare Sector55
Healthcare Sector Financing59
Healthcare Infrastructure60
 
Table: Hospital And Beds, 2002-200661
Table: Public Primary Care Facilities, 1994-200461
Table: Medical Personnel by Type, 1995-200662
 
Research & Development63
 
Table: Suggestions Made By University Of Dhaka's Faculty Of Pharmacy To Improve 
 
Pharmaceutical Research64
Clinical Trials65
Regulatory Development67
Regulatory Regime67
 
Table: Steps To Establish A Pharmaceutical Manufacturing Unit And Obtain A Drug Manufacturing 
Licence69
 
Counterfeit Drugs69
Intellectual Property70
Pricing & Reimbursement72
Competitive Landscape75
Pharmaceutical Industry75
Domestic Pharmaceutical Industry76
Foreign Pharmaceutical Industry77
Contract Manufacturing77
Foreign Company Developments79
Local Company Developments81
Distribution Sector82
Company Profile84
Eskayef84
Square Pharmaceuticals87
Renata91
Beximco Pharmaceuticals94
Sanofi98
Novartis100
Demographic Forecast103
 
Table: Bangladesh's Population By Age Group, 1990-2020 ('000)104
Table: Bangladesh's Population By Age Group, 1990-2020 (% of total)105
Table: Bangladesh's Key Population Ratios, 1990-2020106
Table: Bangladesh's Rural And Urban Population, 1990-2020106
 
Glossary107
Methodology109
Pharmaceutical Expenditure Forecast Model109
Healthcare Expenditure Forecast Model109
Notes On Methodology110
Risk/Reward Ratings Methodology111
Ratings Overview112
 
Table: Pharmaceutical Risk/Reward Ratings Indicators112
 
Indicator Weightings113
Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +